Home FDA labels 995ec299-9aea-47a1-ad1e-a69e756df5b0 FDA label 995ec299-9aea-47a1-ad1e-a69e756df5b0 openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID 2452871a-2e35-424f-afcc-7bbdf0df7b45
SPL ID 995ec299-9aea-47a1-ad1e-a69e756df5b0
Version 4
Effective date 2025-05-01
Source export date 2026-10-22
Source partition 8
Source file https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-22/0bafccaf0213baa649cda9c1c2365d28432e10cf46f4167b2ea41290b5cac2b8/drug-label-0008-of-0014.json.zip
Source manifest SHA-256 5de9d3c3492926d1703b492ae4d29b036ac5be73edfcb92a6cd5eb95a2acef9c
Import run 20261023T001338Z
Imported at 2026-10-23 01:01:28 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 1 matching rows.
adverse reactions ADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin topical powder is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. ( See Error! Hyperlink reference not valid. )
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.